State Street
BNR

State Street’s Burning Rock Biotech BNR Stock Holding History

State Street’s Portfolio BNR Stock Details BNR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,696
Closed -$48.8K – 4368
2024
Q1 		$48.8K Sell
6,696
-6
-0.1% -$50 ﹤0.01% 4163
2023
Q4 		$62.3K Hold
6,702
– – ﹤0.01% 4156
2023
Q3 		$65K Sell
6,702
-4,050
-38% -$63.2K ﹤0.01% 4219
2023
Q2 		$234K Buy
10,752
+567
+6% +$15K ﹤0.01% 3947
2023
Q1 		$286K Sell
10,185
-35
-0.3% -$1.05K ﹤0.01% 3941
2022
Q4 		$230K Sell
10,220
-25,021
-71% -$571K ﹤0.01% 4049
2022
Q3 		$842K Buy
35,241
+14,251
+68% +$460K ﹤0.01% 3634
2022
Q2 		$611K Buy
20,990
+1,331
+7% +$59.4K ﹤0.01% 3759
2022
Q1 		$1.83M Buy
19,659
+2,246
+13% +$195K ﹤0.01% 3603
2021
Q4 		$1.66M Sell
17,413
-38,770
-69% -$5.31M ﹤0.01% 3690
2021
Q3 		$10M Buy
56,183
+4,603
+9% +$1.02M ﹤0.01% 2883
2021
Q2 		$15.2M Buy
+51,580
New +$15.3M ﹤0.01% 2667

Other funds holding BNR

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street's BNR Position: Q2 2024 in Review

State Street sold out of Burning Rock Biotech (BNR) in Q2 2024, closing a stake of 6,696 shares — an estimated $48.8K sold.

State Street first reported a position in BNR in Q2 2021 and held it in 12 quarters. The position peaked at $15.2M in Q2 2021. 18 funds tracked by Wall St. Rank hold BNR as of Q2 2024.

  • State Street reported no remaining Burning Rock Biotech position as of Q2 2024 after selling out during the quarter.
  • State Street sold 6,696 Burning Rock Biotech shares in Q2 2024, an estimated $48.8K.
  • State Street first reported a position in Burning Rock Biotech in Q2 2021 and held it in 12 quarters.
  • State Street's Burning Rock Biotech position peaked at $15.2M in Q2 2021.
  • 18 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.